Privately-held California, USA-based drug developer Ashvattha Therapeutics announced positive top-line end-of-study results ...

Chicago-based private equity firm GTCR has agreed to acquire Czech generic drugmaker Zentiva from Advent International in a ...

Private equity firm GTCR has bought Czech Republic-based generics company Zentiva for a reported 4.1 billion euros ($4.8 ...

Uni-Bio Science Group today revealed a strategic cooperation agreement with fellow Hong Kong-based Kexing Biopharm, a leading ...

Intercept Pharmaceuticals, a wholly-owned biopharmaceutical subsidiary of Italy’s privately-held Alfasigma, has announced its ...

FibroGen closed 8% higher Thursday after a settlement was announced in a case involving Kin-Hung Peony Yu, the company’s ...

US biotech Dewpoint Therapeutics, a specialist in transforming condensate biology into medicine, has announced the closing of ...

CAR-T therapies were once confined to oncology wards. Today, they are making headlines in rheumatology and immunology, where early studies suggest a single infusion can reset the immune system of ...

California, USA-based clinical-stage biotech Maze Therapeutics closed up 54.8% at $24.80 yesterday, after it revealed it has ...

AbbVie (NYSE: ABBV) said in a regulatory filing that it has resolved all litigation with manufacturers seeking to market ...

Swiss contract development and manufacturing group Lonza has appointed Jason Berndt as head of group operations, executive ...

Revolution Medicines (Nasdaq: RVMD) said Tuesday that it is advancing daraxonrasib into Phase III testing for pancreatic ...